Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma
Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Long-Term Outcomes Stable After Breast Reconstruction
Stability seen in both long-term surgeon- and patient-reported outcomes data
No Link Between Hyperthyroidism Treatment, Solid Cancer Death
Association between radioactive iodine treatment and solid cancer mortality is dose dependent
Model Better Predicts Lung Cancer Risk for African Americans
Sensitivity for lung cancer screening greater with PLCOm2012 model than USPSTF criteria
August 2020 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for August 2020. This roundup includes...
MASCC/ISOO Update Guidelines for Management of Mucositis
Topics include basic oral care, photobiomodulation therapy, cryotherapy, natural interventions
Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction
But calls made the evening of dermatology surgery can identify patients with active pain
Delayed Radiotherapy Not Tied to Worse Survival in Prostate Cancer
Initiation of RT up to six months after androgen deprivation therapy not tied to worse overall survival
AI Model Using Chest X-Ray May Predict 12-Year Lung Cancer Risk
CXR-LC model had better discrimination than CMS eligibility, similar performance to PLCO Model 2012
Losing Weight Before Midlife Cuts Mortality Risk
Risk lower for those who dropped from obese to overweight versus those who remained obese
